Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma
In conclusion, using metabolomics, biochemical differences between resectable PDAC and HV were detected. These differences indicate metabolic plasticity and utilization of alternative fuel sources.
Authors
- Zaed Hamady (ORCID: https://orcid.org/0000-0002-4591-5226)
- Sam Wilding (ORCID: https://orcid.org/0000-0003-4184-2821)
- Jonathan R. Swann (ORCID: https://orcid.org/0000-0002-6485-4529)
- Umar Niazi (ORCID: https://orcid.org/0000-0001-7176-8883)
- Gareth Griffiths (ORCID: https://orcid.org/0000-0002-9579-8021)
- Declan McDonnell (ORCID: https://orcid.org/0000-0001-9088-9875)
- Paul R. Afolabi (ORCID: https://orcid.org/0000-0002-0553-1578)
- Christopher D. Byrne (ORCID: https://orcid.org/0000-0001-6322-7753)
Institutions
- Cancer Research UK (GB)
- University Hospital Southampton NHS Foundation Trust (GB)
- University of Southampton (GB)
Publication Details
- Journal
- Cancers
- Published
- 2025-03-29
- DOI
- https://doi.org/10.3390/cancers17071150
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Cancer Research UK